🇺🇸 FDA
Patent

US 8758817

Dosage form containing (S)-pantoprazole as active ingredient

granted A61KA61K31/4439A61K9/2081

Quick answer

US patent 8758817 (Dosage form containing (S)-pantoprazole as active ingredient) held by TAKEDA GMBH expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4439, A61K9/2081, A61K9/2846, A61K9/2886